Hydrochloride is the active ingredient in medications containing memantine.
Treatment of moderate to severe Alzheimer's disease.
Symptomatic treatment of cognitive deficits associated with Alzheimer's disease.
Adementis 5mg Tablet (Memantine) is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. It modulates the activity of NMDA receptors in the brain, helping to regulate the flow of calcium ions. This action helps to improve cognitive function and reduce symptoms associated with Alzheimer's disease by potentially reducing excitotoxicity and neuronal damage.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Discard any unused medication after the expiration date.
Dosage should always be determined by a physician and adjusted based on individual patient needs and tolerance.
Generally, treatment begins with a low dose that is gradually increased over several weeks.
Memantine is usually administered orally, once or twice daily.
Headache
Dizziness
Constipation
Nausea
Vomiting
Somnolence (sleepiness)
Confusion
Vertigo
High blood pressure
Hallucinations (rare)
Avoid excessive alcohol consumption as it can worsen side effects.
Caution advised. May cause dizziness or drowsiness. Avoid driving or operating machinery if affected.
Not recommended during pregnancy or breastfeeding. Consult your doctor.
Not approved for use in children.
Dosage adjustment may be necessary for patients with kidney impairment.
Dosage adjustment may be necessary for patients with severe liver impairment.
Your doctor or pharmacist
Prescribing information from the medication's manufacturer
Reputable medical websites (e.g., Mayo Clinic, MedlinePlus)
